News

Gwo Xi Stem Cell Applied Technology Co., Ltd. (TPEx: 6704) is a clinical-stage cell therapy company headquartered in Hsinchu, ...
An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael E Carazo Salas, founder ...
Dr. Wang receives compensation as a member of SELLAS’s Scientific Advisory Board, and this financial relationship has been disclosed to MD Anderson’s Conflict of Interest Committee in accordance with ...
Aberrations in fibroblast growth factor receptors FGFR2/3 are major drivers of many cancers-including intrahepatic ...
Just as infection signals imbalance in Western medicine, in te ao Māori it indicates a deeper disharmony that requires ...
Mesoblast plans to file a BLA for Revascor by year-end after aligning with FDA on trial design, potency assays, and ...
ACROBiosystems has developed a series of specialized proteases for the screening and validation of ADC linkers, focusing on ...
The product, according to its website, is inspired by the "principles of microneedling." It contains tiny spore-like spicules ...